文献速递关节外科

术前阿片类药物使用与全关节置换术后翻修率升高相关:一项系统综述

Preoperative Opioid Use Is Associated With Higher Revision Rates in Total Joint Arthroplasty: A Systematic Review.
PubMed 文献 · J Arthroplasty · 2021-06-24

该系统综述纳入10项研究,比较术前阿片类药物使用者和非使用者接受全髋或全膝关节置换术后的并发症与翻修情况。结果显示,阿片类药物使用组的总体翻修率(4.79%)高于非使用组(1.21%),且无菌性松动、假体周围骨折、脱位及假体周围感染的风险均显著升高。

要点

  • 术前阿片类药物使用与全关节置换术后总体翻修率升高相关。
  • 使用组无菌性松动、假体周围骨折和脱位的风险显著高于非使用组。
  • 6项报告假体周围感染的研究中5项显示术前阿片使用与感染率升高显著相关。

核心结论

  • 有强证据表明术前阿片类药物使用与全关节置换术后因无菌性松动、假体周围骨折和脱位导致的更高总体翻修率相关,并增加假体周围感染风险。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索PubMed、EMBASE、Cochrane Library和ISI Web of Science至2020年5月,最终纳入10项研究。

主要发现

  • 阿片类药物使用组总体翻修率为4.79%(3846/80303),非使用组为1.21%(43719/3613211)。
  • 6项报告假体周围感染率的研究中5项显示术前阿片使用与更高感染率显著相关。

关键数值与推荐

  • 共纳入10项研究,代表87165名阿片类药物使用者和5214010名非使用者。
  • 证据等级为Level III,系统综述。

临床怎么用

  • 在全关节置换术前评估中,应关注患者的术前阿片类药物使用史,并将其视为术后翻修和并发症风险升高的潜在因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although preoperative opioid use has been associated with poor postoperative patient-reported outcome measures and delayed return to work in patients undergoing total joint arthroplasty, direct surgery-related complications in patients on chronic opioids are still not clear. Thus, we sought to perform a systematic review of the literature to evaluate the influence of preoperative opioid use on postoperative complications and revision following primary total joint arthroplasty. METHODS: Following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, we queried PubMed, EMBASE, the Cochrane Library, and the ISI Web of Science for studies investigating the influence of preoperative opioid use on postoperative complications following total hip arthroplasty and total knee arthroplasty up to May 2020. RESULTS: After applying exclusion criteria, 10 studies were included in the analysis which represented 87,165 opioid users (OU) and 5,214,010 nonopioid users (NOU). The overall revision rate in the OU group was 4.79% (3846 of 80,303 patients) compared to 1.21% in the NOU group (43,719 of 3,613,211 patients). There was a higher risk of aseptic loosening (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.11-1.53, P = .002), periprosthetic fractures (OR 1.89, 95% CI 1.53-2.34, P < .00001), and dislocations (OR 1.26, 95% CI 1.14-1.39, P < .00001) in the OU group compared to the NOU group. Overall, 5 of 6 studies reporting on periprosthetic joint infection (PJI) rates showed statistically significant correlation between preoperative opioid use and higher PJI rates. CONCLUSION: There is strong evidence that preoperative opioid use is associated with a higher overall revision rate for aseptic loosening, periprosthetic fractures, and dislocation, and an increased risk for PJI. LEVEL OF EVIDENCE: Level III, systematic review.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Malahias MA, Loucas R, Loucas M, et al. Preoperative Opioid Use Is Associated With Higher Revision Rates in Total Joint Arthroplasty: A Systematic Review. J Arthroplasty. 2021. PMID: 34247870. doi:10.1016/j.arth.2021.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。